참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Toluene | HCID 1140 | — |
| 반응물 | Sodium Hydroxide | HCID 14798 | — |
| 반응물 | Lovastatin Acid | HCID 64727 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | Lovastatin | HCID 53232 | — |
반응 단계
The lovastatin acid in the extract was converted into the lactone by heating it to 90° C. for 3 hours (yield of conversion was 99.2%). After cooling to room temperature, the toluene was mixed with 80 ml of water, while the pH was adjusted to pH=10 with NaOH. After separation of the layers, the toluene layer was mixed again with 80 ml of fresh water, while the pH was adjusted to pH=4 with sulfuric acid. After separation of the layers, the toluene layer was treated with 0.1 g of active coal, Norit SX ultra. Subsequently the toluene solution was filtrated and further concentrated to 15 ml by evaporation. Cooling to -10° C. resulted in crystallization. The crystals were washed with 5 ml of cold toluene, and dried under vacuum at room temperature. In these crystals no 4-acetyl lovastatin could be detected, neither by TLC nor by proton NMR.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05989877 |
|---|
| 출처 데이터셋 | uspto-grants-1999_11 |
|---|
| ORD ID | ord-abda88a6abdd43ffbfba02bc17799f14 |
|---|
| 출처 메모 | uspto-grants-1999_11 |
|---|